Free Trial

FactSet Research Systems (FDS) Financials

FactSet Research Systems logo
$463.65 -0.34 (-0.07%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$464.29 +0.64 (+0.14%)
As of 05/23/2025 04:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for FactSet Research Systems

Annual Income Statements for FactSet Research Systems

This table shows FactSet Research Systems' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 8/31/2024 8/31/2023 8/31/2022 8/31/2021 8/31/2020 8/31/2019 8/31/2018 8/31/2017 8/31/2016 8/31/2015
Net Income / (Loss) Attributable to Common Shareholders
537 468 397 400 373 353 267 258 339 241
Consolidated Net Income / (Loss)
537 468 397 400 373 353 267 258 339 241
Net Income / (Loss) Continuing Operations
537 468 397 400 373 353 267 258 339 241
Total Pre-Tax Income
652 584 444 468 427 422 352 344 461 334
Total Operating Income
701 629 475 474 440 438 366 352 350 332
Total Gross Profit
1,191 1,112 973 805 799 772 691 655 640 601
Total Revenue
2,203 2,086 1,844 1,591 1,494 1,435 1,350 1,221 1,127 1,007
Operating Revenue
2,203 2,086 1,844 1,591 1,494 1,435 1,350 1,221 1,127 1,007
Total Cost of Revenue
1,012 973 871 786 695 663 659 567 487 405
Operating Cost of Revenue
1,012 973 871 786 695 663 659 567 487 405
Total Operating Expenses
490 483 497 331 359 334 325 302 290 270
Selling, General & Admin Expense
485 457 433 331 343 334 325 302 290 270
Impairment Charge
4.68 26 64 0.00 17 - - - - -
Total Other Income / (Expense), net
-50 -45 -32 -6.39 -13 -16 -14 -7.82 111 1.84
Interest Expense
66 66 36 - - - - - - -
Interest & Investment Income
14 13 6.18 -6.39 -9.83 0.55 1.92 -6.60 -1.14 1.84
Other Income / (Expense), net
1.54 8.26 -2.37 - -2.70 -17 -16 -1.22 112 0.00
Income Tax Expense
114 116 47 68 54 69 85 86 122 93
Basic Earnings per Share
$14.11 $12.26 $10.48 $10.56 $9.83 $9.25 $6.90 $6.55 $8.29 $5.80
Weighted Average Basic Shares Outstanding
38.06M 38.19M 37.86M 37.86M 37.94M 38.14M 38.73M 39.44M 40.88M 41.57M
Diluted Earnings per Share
$13.91 $12.04 $10.25 $10.36 $9.65 $9.08 $6.78 $6.51 $8.19 $5.71
Weighted Average Diluted Shares Outstanding
38.62M 38.90M 38.74M 38.57M 38.65M 38.87M 39.38M 39.64M 41.37M 42.24M
Weighted Average Basic & Diluted Shares Outstanding
37.99M 37.99M 38.08M 37.64M 37.99M 37.94M 38.70M 39.40M 40.90M 41.60M

Quarterly Income Statements for FactSet Research Systems

This table shows FactSet Research Systems' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
Period end date 2/28/2025 11/30/2024 8/31/2024 5/31/2024 2/29/2024 11/30/2023 8/31/2023 5/31/2023 2/28/2023 11/30/2022 8/31/2022
Net Income / (Loss) Attributable to Common Shareholders
145 150 89 158 141 149 65 135 132 137 104
Consolidated Net Income / (Loss)
145 150 89 158 141 149 65 135 132 137 104
Net Income / (Loss) Continuing Operations
145 150 89 158 141 149 65 135 132 137 104
Total Pre-Tax Income
172 180 117 191 169 175 107 162 157 158 116
Total Operating Income
185 191 128 202 182 189 116 172 169 172 132
Total Gross Profit
301 310 304 306 291 291 272 288 274 278 257
Total Revenue
571 569 562 553 546 542 536 530 515 505 499
Operating Revenue
571 569 562 553 546 542 536 530 515 505 499
Total Cost of Revenue
270 259 258 247 255 252 264 242 241 227 242
Operating Cost of Revenue
270 259 258 247 255 252 264 242 241 227 242
Total Operating Expenses
116 119 176 103 109 102 156 116 105 106 125
Selling, General & Admin Expense
116 119 173 103 109 102 131 116 105 106 124
Total Other Income / (Expense), net
-13 -12 -11 -12 -13 -14 -8.79 -9.96 -12 -14 -16
Interest Expense
14 14 16 17 17 17 17 16 17 17 -
Interest & Investment Income
0.27 2.70 4.02 4.57 2.85 3.01 4.62 3.08 2.90 2.21 5.21
Other Income / (Expense), net
0.47 0.10 0.80 0.40 0.46 -0.12 3.28 3.31 1.35 0.32 -1.49
Income Tax Expense
27 30 28 32 28 27 42 27 25 21 12
Basic Earnings per Share
$3.81 $3.95 $2.35 $4.15 $3.70 $3.91 $1.71 $3.52 $3.44 $3.59 $2.74
Weighted Average Basic Shares Outstanding
38.02M 38.01M 38.06M 38.09M 38.10M 38.02M 38.19M 38.28M 38.28M 38.12M 37.86M
Diluted Earnings per Share
$3.76 $3.89 $2.33 $4.09 $3.65 $3.84 $1.68 $3.46 $3.38 $3.52 $2.69
Weighted Average Diluted Shares Outstanding
38.51M 38.52M 38.62M 38.64M 38.65M 38.64M 38.90M 38.91M 38.98M 38.91M 38.74M
Weighted Average Basic & Diluted Shares Outstanding
37.95M 38.03M 37.99M 38.04M 38.12M 38.09M 37.99M 38.15M 38.32M 38.25M 38.08M
Cash Dividends to Common per Share
$1.04 $1.04 - - - $0.98 - - - - -

Annual Cash Flow Statements for FactSet Research Systems

This table details how cash moves in and out of FactSet Research Systems' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 8/31/2024 8/31/2023 8/31/2022 8/31/2021 8/31/2020 8/31/2019 8/31/2018 8/31/2017 8/31/2016 8/31/2015
Net Change in Cash & Equivalents
-2.47 -78 -179 96 226 151 17 -34 69 43
Net Cash From Operating Activities
700 646 538 555 506 427 386 321 331 306
Net Cash From Continuing Operating Activities
700 646 538 555 506 427 386 321 331 306
Net Income / (Loss) Continuing Operations
537 468 397 400 373 353 267 258 339 241
Consolidated Net Income / (Loss)
537 468 397 400 373 353 267 258 339 241
Depreciation Expense
125 105 87 64 58 60 57 48 38 31
Amortization Expense
30 32 43 43 43 0.00 0.00 - - -
Non-Cash Adjustments To Reconcile Net Income
29 88 72 2.32 64 32 32 25 -101 -2.61
Changes in Operating Assets and Liabilities, net
-21 -48 -60 46 -32 -19 30 -11 55 37
Net Cash From Investing Activities
-144 -95 -2,034 -136 -74 -56 -49 -347 -158 -65
Net Cash From Continuing Investing Activities
-144 -95 -2,034 -136 -74 -56 -49 -347 -158 -65
Purchase of Property, Plant & Equipment
-86 -61 -51 -61 -78 -59 -34 -37 -48 -26
Acquisitions
0.00 -24 -1,982 -58 0.00 0.00 -15 -303 -263 -35
Purchase of Investments
-59 -11 -0.88 -19 -2.74 -11 -12 -31 -18 -24
Net Cash From Financing Activities
-561 -632 1,339 -323 -218 -214 -320 -8.16 -91 -187
Net Cash From Continuing Financing Activities
-561 -632 1,339 -323 -218 -214 -320 -8.16 -91 -187
Repayment of Debt
-267 -389 -841 -4.26 -3.53 -576 0.00 -367 -0.01 -0.03
Repurchase of Common Equity
-235 -177 -19 -265 -200 -220 -304 -261 -357 -256
Payment of Dividends
-151 -139 -126 -118 -110 -100 -89 -81 -74 -67
Issuance of Debt
0.00 0.00 2,238 0.00 0.00 575 1.72 640 265 35
Issuance of Common Equity
92 72 86 64 96 107 72 50 57 72
Effect of Exchange Rate Changes
2.36 4.02 -22 -0.26 12 -5.59 - 1.26 -12 -12
Cash Interest Paid
66 77 30 8.02 13 20 16 8.47 3.01 -
Cash Income Taxes Paid
157 91 76 47 69 90 69 75 88 65

Quarterly Cash Flow Statements for FactSet Research Systems

This table details how cash moves in and out of FactSet Research Systems' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
Period end date 2/28/2025 11/30/2024 8/31/2024 5/31/2024 2/29/2024 11/30/2023 8/31/2023 5/31/2023 2/28/2023 11/30/2022 8/31/2022
Net Change in Cash & Equivalents
2.42 -134 -30 71 -30 -14 -61 41 8.18 -66 -24
Net Cash From Operating Activities
174 86 163 238 144 155 156 219 165 107 151
Net Cash From Continuing Operating Activities
174 86 163 238 144 155 156 219 165 107 151
Net Income / (Loss) Continuing Operations
145 150 89 158 141 149 65 135 132 137 104
Consolidated Net Income / (Loss)
145 150 89 158 141 149 65 135 132 137 104
Depreciation Expense
38 36 34 33 32 27 27 26 26 26 27
Amortization Expense
7.61 7.57 7.56 7.58 7.65 7.62 3.10 9.65 9.90 9.70 10
Non-Cash Adjustments To Reconcile Net Income
29 4.72 13 4.06 6.65 8.39 42 17 27 1.22 4.02
Changes in Operating Assets and Liabilities, net
-46 -112 19 36 -43 -36 18 31 -30 -67 6.31
Net Cash From Investing Activities
-193 -145 -40 -21 -58 -25 -23 -26 -18 -28 -15
Net Cash From Continuing Investing Activities
-193 -145 -40 -21 -58 -25 -23 -26 -18 -28 -15
Purchase of Property, Plant & Equipment
-24 -26 -26 -21 -22 -16 0.64 -26 -17 -18 -15
Acquisitions
-227 -115 - - - 0.00 - - - - -
Purchase of Investments
-0.22 -3.99 -14 - -36 -8.75 -0.13 - -1.00 -9.89 -0.20
Net Cash From Financing Activities
25 -70 -158 -144 -115 -145 -195 -152 -139 -146 -149
Net Cash From Continuing Financing Activities
25 -70 -158 -144 -115 -145 -195 -152 -139 -146 -149
Repayment of Debt
-143 -76 -63 -64 -63 -76 -64 -63 -126 -136 -128
Repurchase of Common Equity
-64 -49 -63 -60 -52 -60 -110 -67 - 0.00 -
Payment of Dividends
-40 -39 -39 -37 -37 -37 -37 -34 -34 -34 -34
Issuance of Debt
250 55 - - - 0.00 - - - - -
Issuance of Common Equity
21 39 8.21 17 38 28 16 12 20 23 12
Effect of Exchange Rate Changes
-3.00 -5.05 4.28 -1.78 -1.18 1.05 0.90 0.42 1.38 1.32 -10

Annual Balance Sheets for FactSet Research Systems

This table presents FactSet Research Systems' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 8/31/2024 8/31/2023 8/31/2022 8/31/2021 8/31/2020 8/31/2019 8/31/2018 8/31/2017 8/31/2016 8/31/2015
Total Assets
4,055 3,963 4,014 2,225 2,083 1,560 1,419 1,413 1,019 737
Total Current Assets
836 770 870 934 842 584 431 409 369 304
Cash & Equivalents
423 425 503 682 586 360 209 195 228 159
Short-Term Investments
70 32 33 36 20 26 29 32 24 23
Accounts Receivable
228 238 204 151 155 146 157 148 98 95
Prepaid Expenses
60 51 91 51 44 37 30 24 16 20
Current Deferred & Refundable Income Taxes
55 24 39 14 38 15 6.27 9.74 3.16 6.91
Plant, Property, & Equipment, net
83 86 81 131 133 119 101 100 85 59
Total Noncurrent Assets
3,137 3,107 3,063 1,160 1,108 857 888 903 565 373
Goodwill
1,011 1,005 966 754 710 686 702 708 453 308
Intangible Assets
1,844 1,859 1,896 135 121 124 149 174 93 40
Noncurrent Deferred & Refundable Income Taxes
61 27 3.15 2.25 - 7.57 9.72 7.41 13 21
Other Noncurrent Operating Assets
220 216 198 269 278 39 28 15 5.78 4.30
Total Liabilities & Shareholders' Equity
4,055 3,963 4,014 2,225 2,083 1,560 1,419 1,413 1,019 737
Total Liabilities
2,143 2,343 2,683 1,209 1,187 888 894 854 502 205
Total Current Liabilities
667 484 438 316 276 219 221 201 158 140
Short-Term Debt
125 0.00 - - - - - - - -
Accounts Payable
178 122 108 86 82 80 72 59 46 34
Dividends Payable
39 37 34 31 29 27 24 22 20 18
Current Deferred Revenue
160 152 152 63 54 48 50 47 33 38
Current Deferred & Payable Income Tax Liabilities
40 31 0.00 - - - 8.45 11 8.07 4.32
Current Employee Benefit Liabilities
93 113 115 104 82 64 66 61 51 45
Other Current Liabilities
31 29 29 32 29 0.00 - - - -
Total Noncurrent Liabilities
1,476 1,859 2,245 893 911 669 672 652 344 65
Long-Term Debt
1,241 1,613 1,982 575 574 574 575 575 300 35
Noncurrent Deferred Revenue
42 34 41 39 37 36 30 15 8.78 6.78
Noncurrent Deferred & Payable Income Tax Liabilities
8.45 6.74 8.80 15 20 16 21 25 1.71 1.70
Other Noncurrent Operating Liabilities
184 205 212 265 280 42 47 37 33 22
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Total Equity & Noncontrolling Interests
1,912 1,620 1,331 1,016 896 672 526 560 517 532
Total Preferred & Common Equity
1,912 1,620 1,331 1,016 896 672 526 560 517 532
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,912 1,620 1,331 1,016 896 672 526 560 517 532
Common Stock
1,479 1,324 1,191 1,049 939 807 668 742 624 543
Retained Earnings
1,889 1,505 1,180 913 633 373 123 1,459 1,284 1,022
Treasury Stock
-1,376 -1,122 -931 -906 -637 -434 -213 -1,607 -1,322 -989
Accumulated Other Comprehensive Income / (Loss)
-80 -87 -108 -39 -39 -75 -51 -35 -69 -44

Quarterly Balance Sheets for FactSet Research Systems

This table presents FactSet Research Systems' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
Period end date 2/28/2025 11/30/2024 8/31/2024 5/31/2024 2/29/2024 11/30/2023 8/31/2023 5/31/2023 2/28/2023 11/30/2022 8/31/2022
Total Assets
4,241 4,049 4,055 4,040 3,991 3,951 3,963 3,998 4,001 3,978 4,014
Total Current Assets
708 751 836 858 823 766 770 844 859 829 870
Cash & Equivalents
279 289 423 453 382 412 425 487 445 437 503
Short-Term Investments
8.47 70 70 69 69 32 32 32 32 33 33
Accounts Receivable
278 253 228 240 272 245 238 238 257 227 204
Prepaid Expenses
67 61 60 52 58 51 51 66 82 100 91
Current Deferred & Refundable Income Taxes
76 79 55 44 43 26 24 22 42 32 39
Plant, Property, & Equipment, net
80 82 83 81 81 83 86 82 82 79 81
Total Noncurrent Assets
3,454 3,216 3,137 3,101 3,087 3,102 3,107 3,072 3,061 3,069 3,063
Goodwill
1,245 1,092 1,011 1,005 1,004 1,005 1,005 982 977 975 966
Intangible Assets
1,935 1,870 1,844 1,851 1,861 1,848 1,859 1,859 1,870 1,883 1,896
Noncurrent Deferred & Refundable Income Taxes
54 40 61 37 24 24 27 12 5.66 3.65 3.15
Other Noncurrent Operating Assets
220 214 220 208 198 225 216 218 208 208 198
Total Liabilities & Shareholders' Equity
4,241 4,049 4,055 4,040 3,991 3,951 3,963 3,998 4,001 3,978 4,014
Total Liabilities
2,185 2,057 2,143 2,149 2,189 2,250 2,343 2,329 2,394 2,503 2,683
Total Current Liabilities
482 538 667 672 460 456 484 401 411 384 438
Short-Term Debt
0.00 62 125 187 29 - 0.00 - - - -
Accounts Payable
131 151 178 138 128 150 122 110 120 123 108
Dividends Payable
40 40 39 40 37 37 37 37 34 34 34
Current Deferred Revenue
177 157 160 168 175 150 152 148 164 150 152
Current Deferred & Payable Income Tax Liabilities
30 45 40 29 18 37 31 - - - 0.00
Current Employee Benefit Liabilities
71 52 93 79 72 52 113 76 64 48 115
Other Current Liabilities
33 31 31 30 - 29 29 30 29 29 29
Total Noncurrent Liabilities
1,703 1,519 1,476 1,478 1,729 1,795 1,859 1,928 1,983 2,119 2,245
Long-Term Debt
1,472 1,297 1,241 1,241 1,489 1,551 1,613 1,674 1,736 1,859 1,982
Noncurrent Deferred Revenue
47 43 42 39 39 35 34 44 41 44 41
Noncurrent Deferred & Payable Income Tax Liabilities
15 15 8.45 7.94 8.23 9.33 6.74 6.07 6.60 11 8.80
Other Noncurrent Operating Liabilities
169 164 184 191 6.97 199 205 204 200 205 212
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,057 1,992 1,912 1,890 1,802 1,701 1,620 1,669 1,607 1,474 1,331
Total Preferred & Common Equity
2,057 1,992 1,912 1,890 1,802 1,701 1,620 1,669 1,607 1,474 1,331
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
2,057 1,992 1,912 1,890 1,802 1,701 1,620 1,669 1,607 1,474 1,331
Common Stock
1,570 1,532 1,479 1,454 1,422 1,367 1,324 1,291 1,262 1,226 1,191
Retained Earnings
2,104 1,999 1,889 1,838 1,720 1,616 1,505 1,477 1,380 1,283 1,180
Treasury Stock
-1,504 -1,439 -1,376 -1,310 -1,249 -1,195 -1,122 -1,010 -942 -942 -931
Accumulated Other Comprehensive Income / (Loss)
-113 -100 -80 -93 -91 -87 -87 -89 -92 -93 -108

Annual Metrics And Ratios for FactSet Research Systems

This table displays calculated financial ratios and metrics derived from FactSet Research Systems' official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 8/31/2024 8/31/2023 8/31/2022 8/31/2021 8/31/2020 8/31/2019 8/31/2018 8/31/2017 8/31/2016 8/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
5.64% 13.10% 15.86% 6.51% 4.09% 6.31% 10.56% 8.35% 11.95% 9.39%
EBITDA Growth
10.74% 28.59% 3.69% 8.11% 11.60% 18.34% 2.00% -20.19% 37.69% 7.51%
EBIT Growth
10.25% 34.74% -0.20% 8.49% 3.69% 20.43% -0.28% -24.07% 39.23% 9.38%
NOPAT Growth
14.62% 18.57% 5.03% 5.52% 4.82% 31.74% 5.25% 2.77% 7.21% 13.79%
Net Income Growth
14.73% 17.95% -0.67% 7.15% 5.71% 32.09% 3.42% -23.78% 40.56% 13.95%
EPS Growth
15.53% 17.46% -1.06% 7.36% 6.28% 33.92% 4.15% -20.51% 43.43% 16.06%
Operating Cash Flow Growth
8.48% 19.93% -3.05% 9.76% 18.43% 10.75% 20.32% -3.21% 8.06% 15.63%
Free Cash Flow Firm Growth
12.26% 133.97% -474.18% 4.96% 3.31% 14.08% 497.83% -207.90% -67.34% 36.53%
Invested Capital Growth
0.46% 0.04% 211.01% 1.01% 0.74% 0.12% -4.53% 58.93% 45.34% 2.90%
Revenue Q/Q Growth
1.21% 1.78% 4.98% 1.81% 1.31% 1.30% 1.44% 3.33% 2.32% 2.35%
EBITDA Q/Q Growth
2.52% -1.86% 3.50% 3.95% 5.34% 1.83% -2.50% -22.11% 31.37% 0.87%
EBIT Q/Q Growth
1.34% -1.22% 2.31% 4.92% -3.47% 1.59% -2.88% -25.17% 33.80% 1.40%
NOPAT Q/Q Growth
4.93% -8.64% 4.17% 2.64% -0.76% 6.35% 4.05% 0.03% 0.01% 2.85%
Net Income Q/Q Growth
4.75% -7.74% 0.85% 3.09% -0.65% 6.88% 3.60% -24.71% 31.99% 2.89%
EPS Q/Q Growth
4.90% -7.74% 0.69% 3.29% -0.62% 6.82% 3.99% -23.50% 32.95% 3.26%
Operating Cash Flow Q/Q Growth
1.08% 0.67% -5.88% 4.82% 8.03% 3.76% 1.61% 10.39% -3.94% 4.18%
Free Cash Flow Firm Q/Q Growth
-2.05% -6.19% -0.29% 12.91% 0.24% 10.75% 4.31% -64.95% 78.82% 0.20%
Invested Capital Q/Q Growth
-0.37% -1.73% -1.23% -5.85% -2.33% -1.93% -0.43% -0.16% -5.38% -0.09%
Profitability Metrics
- - - - - - - - - -
Gross Margin
54.07% 53.33% 52.76% 50.59% 53.45% 53.78% 51.17% 53.60% 56.76% 59.74%
EBITDA Margin
38.97% 37.17% 32.69% 36.53% 35.99% 33.57% 30.16% 32.69% 44.38% 36.08%
Operating Margin
31.83% 30.17% 25.79% 29.79% 29.43% 30.52% 27.12% 28.84% 31.02% 32.97%
EBIT Margin
31.90% 30.57% 25.66% 29.79% 29.25% 29.36% 25.92% 28.74% 41.00% 32.97%
Profit (Net Income) Margin
24.38% 22.45% 21.53% 25.11% 24.96% 24.58% 19.78% 21.15% 30.06% 23.94%
Tax Burden Percent
82.44% 80.17% 89.48% 85.45% 87.31% 83.61% 75.91% 75.01% 73.50% 72.22%
Interest Burden Percent
92.70% 91.61% 93.76% 98.64% 97.75% 100.13% 100.55% 98.12% 99.75% 100.55%
Effective Tax Rate
17.56% 19.83% 10.52% 14.55% 12.69% 16.39% 24.09% 24.99% 26.50% 27.78%
Return on Invested Capital (ROIC)
20.51% 17.94% 22.90% 45.04% 43.06% 41.25% 30.61% 34.89% 52.07% 60.43%
ROIC Less NNEP Spread (ROIC-NNEP)
16.61% 15.23% 18.73% 54.67% 32.86% 36.60% 27.62% 32.20% -212.54% 59.37%
Return on Net Nonoperating Assets (RNNOA)
9.90% 13.79% 10.91% -3.26% 4.49% 17.64% 18.60% 13.07% 12.53% -14.20%
Return on Equity (ROE)
30.41% 31.73% 33.81% 41.78% 47.55% 58.89% 49.21% 47.96% 64.60% 46.24%
Cash Return on Invested Capital (CROIC)
20.05% 17.90% -79.78% 44.03% 42.32% 41.14% 35.24% -10.63% 15.11% 57.57%
Operating Return on Assets (OROA)
17.53% 15.98% 15.17% 22.01% 23.99% 28.29% 24.71% 28.85% 52.64% 47.42%
Return on Assets (ROA)
13.40% 11.74% 12.72% 18.55% 20.47% 23.68% 18.86% 21.23% 38.59% 34.44%
Return on Common Equity (ROCE)
30.41% 31.73% 33.81% 41.78% 47.55% 58.89% 49.21% 47.96% 64.60% 46.24%
Return on Equity Simple (ROE_SIMPLE)
28.09% 28.90% 29.81% 39.32% 41.61% 52.48% 50.79% 46.14% 65.49% 45.35%
Net Operating Profit after Tax (NOPAT)
578 504 425 405 384 366 278 264 257 240
NOPAT Margin
26.24% 24.19% 23.07% 25.45% 25.69% 25.51% 20.59% 21.63% 22.80% 23.81%
Net Nonoperating Expense Percent (NNEP)
3.90% 2.72% 4.17% -9.63% 10.20% 4.65% 2.98% 2.69% 264.61% 1.06%
Cost of Revenue to Revenue
45.93% 46.67% 47.24% 49.41% 46.55% 46.22% 48.83% 46.40% 43.24% 40.26%
SG&A Expenses to Revenue
22.02% 21.92% 23.48% 20.80% 22.92% 23.26% 24.05% 24.77% 25.73% 26.77%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
22.23% 23.16% 26.97% 20.80% 24.03% 23.26% 24.05% 24.77% 25.73% 26.77%
Earnings before Interest and Taxes (EBIT)
703 637 473 474 437 421 350 351 462 332
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
858 775 603 581 538 482 407 399 500 363
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
8.41 10.18 12.14 13.80 14.36 14.82 15.85 10.31 12.93 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 110.29 196.31 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
7.30 7.91 8.76 8.81 8.62 6.94 6.17 4.73 5.94 0.00
Price to Earnings (P/E)
29.95 35.23 40.72 35.10 34.52 28.25 31.20 22.35 19.74 0.00
Dividend Yield
0.96% 0.87% 0.80% 0.86% 0.88% 1.04% 1.10% 1.44% 1.14% 1.15%
Earnings Yield
3.34% 2.84% 2.46% 2.85% 2.90% 3.54% 3.20% 4.47% 5.06% 0.00%
Enterprise Value to Invested Capital (EV/IC)
6.00 6.28 6.26 15.36 14.35 11.43 9.77 6.59 11.52 0.00
Enterprise Value to Revenue (EV/Rev)
7.70 8.46 9.55 8.72 8.60 7.07 6.42 5.01 5.98 0.00
Enterprise Value to EBITDA (EV/EBITDA)
19.76 22.77 29.21 23.88 23.88 21.07 21.29 15.33 13.47 0.00
Enterprise Value to EBIT (EV/EBIT)
24.13 27.68 37.21 29.28 29.39 24.10 24.78 17.44 14.58 0.00
Enterprise Value to NOPAT (EV/NOPAT)
29.33 34.98 41.38 34.27 33.45 27.73 31.19 23.17 26.21 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
24.21 27.34 32.71 25.00 25.39 23.77 22.48 19.10 20.34 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
30.01 35.06 0.00 35.05 34.04 27.80 27.09 0.00 90.33 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.71 1.00 1.49 0.57 0.64 0.85 1.09 1.03 0.58 0.07
Long-Term Debt to Equity
0.65 1.00 1.49 0.57 0.64 0.85 1.09 1.03 0.58 0.07
Financial Leverage
0.60 0.91 0.58 -0.06 0.14 0.48 0.67 0.41 -0.06 -0.24
Leverage Ratio
2.27 2.70 2.66 2.25 2.32 2.49 2.61 2.26 1.67 1.34
Compound Leverage Factor
2.10 2.48 2.49 2.22 2.27 2.49 2.62 2.22 1.67 1.35
Debt to Total Capital
41.67% 49.89% 59.82% 36.11% 39.05% 46.07% 52.22% 50.67% 36.70% 6.18%
Short-Term Debt to Total Capital
3.81% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
37.86% 49.89% 59.82% 36.11% 39.05% 46.07% 52.22% 50.67% 36.70% 6.18%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
58.33% 50.11% 40.18% 63.89% 60.95% 53.93% 47.78% 49.33% 63.30% 93.82%
Debt to EBITDA
1.59 2.08 3.29 0.99 1.07 1.19 1.41 1.44 0.60 0.10
Net Debt to EBITDA
1.02 1.49 2.40 -0.25 -0.06 0.39 0.83 0.87 0.09 -0.41
Long-Term Debt to EBITDA
1.45 2.08 3.29 0.99 1.07 1.19 1.41 1.44 0.60 0.10
Debt to NOPAT
2.36 3.20 4.66 1.42 1.50 1.57 2.07 2.18 1.17 0.15
Net Debt to NOPAT
1.51 2.29 3.40 -0.35 -0.08 0.51 1.21 1.32 0.18 -0.61
Long-Term Debt to NOPAT
2.15 3.20 4.66 1.42 1.50 1.57 2.07 2.18 1.17 0.15
Altman Z-Score
6.32 5.90 5.00 9.29 8.67 9.16 7.66 7.36 12.61 0.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.25 1.59 1.99 2.96 3.05 2.67 1.95 2.04 2.33 2.18
Quick Ratio
1.08 1.44 1.69 2.75 2.75 2.43 1.78 1.87 2.21 1.99
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
565 503 -1,482 396 377 365 320 -80 75 228
Operating Cash Flow to CapEx
817.38% 1,062.04% 1,052.23% 905.38% 651.50% 719.45% 1,150.56% 869.53% 693.63% 1,193.22%
Free Cash Flow to Firm to Interest Expense
8.59 7.59 -41.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
10.65 9.73 15.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
9.34 8.82 13.65 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.55 0.52 0.59 0.74 0.82 0.96 0.95 1.00 1.28 1.44
Accounts Receivable Turnover
9.46 9.44 10.38 10.39 9.92 9.48 8.85 9.92 11.69 10.86
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
26.13 24.98 17.38 12.03 11.84 13.05 13.43 13.20 15.67 17.22
Accounts Payable Turnover
6.74 8.46 8.97 9.37 8.60 8.75 10.04 10.79 12.23 13.32
Days Sales Outstanding (DSO)
38.58 38.66 35.16 35.11 36.81 38.52 41.22 36.78 31.23 33.61
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
54.12 43.17 40.68 38.96 42.44 41.72 36.34 33.84 29.85 27.40
Cash Conversion Cycle (CCC)
-15.54 -4.51 -5.51 -3.84 -5.63 -3.20 4.89 2.95 1.38 6.21
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
2,825 2,812 2,811 904 895 888 887 929 585 402
Invested Capital Turnover
0.78 0.74 0.99 1.77 1.68 1.62 1.49 1.61 2.28 2.54
Increase / (Decrease) in Invested Capital
13 1.04 1,907 9.05 6.57 1.03 -42 345 182 11
Enterprise Value (EV)
16,958 17,648 17,607 13,881 12,842 10,154 8,671 6,121 6,737 0.00
Market Capitalization
16,085 16,493 16,161 14,024 12,873 9,965 8,334 5,773 6,689 0.00
Book Value per Share
$50.28 $42.47 $35.06 $26.90 $23.59 $17.57 $13.71 $14.27 $12.73 $12.79
Tangible Book Value per Share
($24.78) ($32.61) ($40.29) $3.37 $1.73 ($3.61) ($8.47) ($8.19) ($0.71) $4.41
Total Capital
3,278 3,233 3,314 1,591 1,471 1,246 1,101 1,135 817 567
Total Debt
1,366 1,613 1,982 575 574 574 575 575 300 35
Total Long-Term Debt
1,241 1,613 1,982 575 574 574 575 575 300 35
Net Debt
873 1,155 1,446 -143 -31 189 337 348 47 -147
Capital Expenditures (CapEx)
86 61 51 61 78 59 34 37 48 26
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-199 -172 -104 -100 -40 -21 -28 -19 -42 -18
Debt-free Net Working Capital (DFNWC)
294 286 432 618 566 365 210 208 211 164
Net Working Capital (NWC)
169 286 432 618 566 365 210 208 211 164
Net Nonoperating Expense (NNE)
41 36 29 5.49 11 13 11 5.87 -82 -1.33
Net Nonoperating Obligations (NNO)
913 1,192 1,480 -112 -1.54 216 361 370 67 -129
Total Depreciation and Amortization (D&A)
156 138 130 107 101 60 57 48 38 31
Debt-free, Cash-free Net Working Capital to Revenue
-9.03% -8.24% -5.66% -6.28% -2.65% -1.44% -2.08% -1.55% -3.69% -1.79%
Debt-free Net Working Capital to Revenue
13.33% 13.71% 23.43% 38.82% 37.86% 25.42% 15.54% 17.05% 18.73% 16.33%
Net Working Capital to Revenue
7.66% 13.71% 23.43% 38.82% 37.86% 25.42% 15.54% 17.05% 18.73% 16.33%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$14.11 $12.26 $10.48 $10.56 $9.83 $9.25 $6.90 $6.55 $8.29 $5.80
Adjusted Weighted Average Basic Shares Outstanding
38.06M 38.19M 37.86M 37.86M 37.94M 38.14M 38.73M 39.44M 40.88M 41.57M
Adjusted Diluted Earnings per Share
$13.91 $12.04 $10.25 $10.36 $9.65 $9.08 $6.78 $6.51 $8.19 $5.71
Adjusted Weighted Average Diluted Shares Outstanding
38.62M 38.90M 38.74M 38.57M 38.65M 38.87M 39.38M 39.64M 41.37M 42.24M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
37.99M 37.99M 38.08M 37.64M 37.99M 37.94M 38.04M 39.11M 39.94M 41.45M
Normalized Net Operating Profit after Tax (NOPAT)
582 525 483 405 398 366 278 264 257 240
Normalized NOPAT Margin
26.42% 25.19% 26.19% 25.45% 26.66% 25.51% 20.59% 21.63% 22.80% 23.81%
Pre Tax Income Margin
29.57% 28.00% 24.06% 29.38% 28.59% 29.40% 26.06% 28.20% 40.90% 33.15%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
10.68 9.61 13.25 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
8.79 7.61 11.92 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
9.38 8.70 11.82 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
7.49 6.69 10.49 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
28.05% 29.60% 31.73% 29.51% 29.61% 28.36% 33.48% 31.32% 21.91% 27.61%
Augmented Payout Ratio
71.85% 67.35% 36.42% 95.76% 83.14% 90.83% 147.28% 132.38% 127.22% 133.90%

Quarterly Metrics And Ratios for FactSet Research Systems

This table displays calculated financial ratios and metrics derived from FactSet Research Systems' official financial filings.

Metric Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
Period end date 2/28/2025 11/30/2024 8/31/2024 5/31/2024 2/29/2024 11/30/2023 8/31/2023 5/31/2023 2/28/2023 11/30/2022 8/31/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
4.53% 4.88% 4.93% 4.32% 5.99% 7.41% 7.31% 8.40% 19.48% 18.86% 21.22%
EBITDA Growth
4.67% 4.97% 14.12% 14.93% 7.22% 7.55% -10.85% 56.07% 37.53% 38.84% 14.56%
EBIT Growth
1.96% 1.33% 7.77% 15.74% 6.92% 9.70% -8.68% 80.08% 37.99% 41.83% 9.70%
NOPAT Growth
2.55% -0.37% 38.66% 17.55% 7.02% 7.63% -40.59% 67.33% 27.77% 35.28% 16.62%
Net Income Growth
2.78% 0.99% 37.43% 17.43% 7.10% 8.59% -37.64% 79.77% 19.70% 27.08% 3.32%
EPS Growth
3.01% 1.30% 38.69% 18.21% 7.99% 9.09% -37.55% 79.27% 19.01% 26.16% 2.67%
Operating Cash Flow Growth
20.97% -44.33% 4.81% 8.99% -12.68% 45.49% 2.85% 13.87% 34.94% 46.24% -18.18%
Free Cash Flow Firm Growth
21.65% -112.47% 21.92% 52.31% 97.62% 112.13% 103.88% 107.07% -2,955.17% -1,973.09% -2,030.89%
Invested Capital Growth
6.09% 6.54% 0.46% -0.91% 6.68% -1.80% 0.04% 0.55% 186.04% 191.05% 211.01%
Revenue Q/Q Growth
0.35% 1.15% 1.72% 1.24% 0.69% 1.20% 1.13% 2.86% 2.03% 1.11% 2.16%
EBITDA Q/Q Growth
-1.17% 37.87% -29.92% 9.62% -0.89% 49.89% -29.43% 2.27% -0.58% 23.15% 23.55%
EBIT Q/Q Growth
-2.86% 48.80% -36.58% 11.22% -3.45% 58.25% -31.89% 2.74% -0.94% 30.25% 34.32%
NOPAT Q/Q Growth
-2.36% 63.47% -41.86% 10.51% -5.14% 127.51% -50.71% 0.61% -4.61% 25.60% 38.81%
Net Income Q/Q Growth
-3.44% 67.63% -43.41% 12.20% -5.13% 128.13% -51.64% 2.33% -3.80% 31.01% 39.40%
EPS Q/Q Growth
-3.34% 66.95% -43.03% 12.05% -4.95% 128.57% -51.45% 2.37% -3.98% 30.86% 39.38%
Operating Cash Flow Q/Q Growth
101.40% -47.06% -31.51% 65.67% -7.31% -0.34% -28.78% 32.74% 54.43% -29.54% -21.16%
Free Cash Flow Firm Q/Q Growth
-22.80% -131.31% -56.38% 567.10% -119.54% 206.23% -45.50% 107.30% 0.53% 2.00% 0.66%
Invested Capital Q/Q Growth
8.25% 7.30% -0.37% -8.32% 8.71% 1.17% -1.73% -1.30% 0.07% 3.07% -1.23%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
52.76% 54.49% 54.07% 55.31% 53.27% 53.59% 50.79% 54.38% 53.25% 55.02% 51.54%
EBITDA Margin
40.65% 41.28% 30.28% 43.96% 40.59% 41.24% 27.84% 39.90% 40.13% 41.19% 33.51%
Operating Margin
32.50% 33.65% 22.74% 36.63% 33.33% 34.86% 21.67% 32.46% 32.86% 34.05% 26.48%
EBIT Margin
32.59% 33.66% 22.89% 36.70% 33.41% 34.84% 22.28% 33.08% 33.12% 34.11% 26.18%
Profit (Net Income) Margin
25.38% 26.38% 15.92% 28.61% 25.82% 27.40% 12.15% 25.42% 25.55% 27.10% 20.91%
Tax Burden Percent
84.06% 83.47% 76.41% 83.00% 83.57% 84.79% 60.68% 83.13% 83.94% 86.64% 89.69%
Interest Burden Percent
92.66% 93.89% 91.04% 93.92% 92.46% 92.73% 89.89% 92.43% 91.89% 91.68% 89.06%
Effective Tax Rate
15.94% 16.53% 23.59% 17.00% 16.43% 15.21% 39.32% 16.87% 16.06% 13.36% 10.31%
Return on Invested Capital (ROIC)
19.33% 21.31% 13.58% 23.23% 20.02% 21.86% 9.75% 19.37% 28.31% 29.16% 23.58%
ROIC Less NNEP Spread (ROIC-NNEP)
18.45% 20.42% 12.80% 22.30% 19.16% 20.94% 9.35% 18.77% 26.38% 27.32% 21.50%
Return on Net Nonoperating Assets (RNNOA)
12.03% 12.08% 7.63% 13.40% 14.52% 16.94% 8.47% 17.72% 10.19% 14.02% 12.52%
Return on Equity (ROE)
31.35% 33.39% 21.21% 36.63% 34.54% 38.80% 18.22% 37.09% 38.49% 43.18% 36.10%
Cash Return on Invested Capital (CROIC)
12.33% 13.32% 20.05% 20.25% 11.09% 19.79% 17.90% 18.80% -71.10% -73.86% -79.78%
Operating Return on Assets (OROA)
17.85% 18.76% 12.58% 19.88% 18.01% 18.66% 11.65% 16.81% 20.86% 21.06% 15.48%
Return on Assets (ROA)
13.90% 14.70% 8.75% 15.50% 13.91% 14.67% 6.35% 12.91% 16.09% 16.73% 12.36%
Return on Common Equity (ROCE)
31.35% 33.39% 21.21% 36.63% 34.54% 38.80% 18.22% 37.09% 38.49% 43.18% 36.10%
Return on Equity Simple (ROE_SIMPLE)
26.38% 27.04% 0.00% 27.12% 27.16% 28.22% 0.00% 30.41% 27.86% 28.90% 0.00%
Net Operating Profit after Tax (NOPAT)
156 160 98 168 152 160 70 143 142 149 119
NOPAT Margin
27.33% 28.08% 17.38% 30.40% 27.85% 29.56% 13.15% 26.98% 27.58% 29.50% 23.75%
Net Nonoperating Expense Percent (NNEP)
0.88% 0.89% 0.78% 0.93% 0.86% 0.91% 0.40% 0.60% 1.92% 1.84% 2.07%
Return On Investment Capital (ROIC_SIMPLE)
4.42% 4.77% - - - 4.93% - - - - -
Cost of Revenue to Revenue
47.24% 45.51% 45.93% 44.69% 46.73% 46.41% 49.21% 45.62% 46.75% 44.98% 48.46%
SG&A Expenses to Revenue
20.25% 20.85% 30.69% 18.65% 19.93% 18.73% 24.49% 21.84% 20.30% 20.92% 24.80%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
20.25% 20.85% 31.33% 18.68% 19.94% 18.73% 29.12% 21.93% 20.39% 20.97% 25.06%
Earnings before Interest and Taxes (EBIT)
186 191 129 203 182 189 119 175 171 172 131
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
232 235 170 243 222 224 149 211 207 208 167
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
8.54 9.36 8.41 8.15 9.75 10.03 10.18 8.76 9.75 11.75 12.14
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
7.79 8.36 7.30 7.08 8.16 8.04 7.91 7.13 7.81 9.01 8.76
Price to Earnings (P/E)
32.37 34.61 29.95 30.05 35.92 35.56 35.23 28.80 35.01 40.66 40.72
Dividend Yield
0.90% 0.84% 0.96% 0.98% 0.85% 0.85% 0.87% 0.96% 0.87% 0.77% 0.80%
Earnings Yield
3.09% 2.89% 3.34% 3.33% 2.78% 2.81% 2.84% 3.47% 2.86% 2.46% 2.46%
Enterprise Value to Invested Capital (EV/IC)
5.71 6.48 6.00 5.75 6.09 6.39 6.28 5.51 5.84 6.46 6.26
Enterprise Value to Revenue (EV/Rev)
8.32 8.81 7.70 7.50 8.74 8.56 8.46 7.70 8.43 9.73 9.55
Enterprise Value to EBITDA (EV/EBITDA)
21.30 22.59 19.76 19.48 23.36 22.98 22.77 19.97 23.61 28.28 29.21
Enterprise Value to EBIT (EV/EBIT)
26.44 27.84 24.13 23.52 28.27 27.78 27.68 24.44 29.67 35.67 37.21
Enterprise Value to NOPAT (EV/NOPAT)
32.24 34.00 29.33 29.61 35.80 35.23 34.98 28.56 34.22 40.31 41.38
Enterprise Value to Operating Cash Flow (EV/OCF)
28.33 31.10 24.21 23.55 27.97 26.18 27.34 24.59 27.55 32.72 32.71
Enterprise Value to Free Cash Flow (EV/FCFF)
47.69 50.18 30.01 28.28 56.65 31.99 35.06 29.39 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.72 0.68 0.71 0.76 0.95 0.91 1.00 1.00 1.08 1.26 1.49
Long-Term Debt to Equity
0.72 0.65 0.65 0.66 0.93 0.91 1.00 1.00 1.08 1.26 1.49
Financial Leverage
0.65 0.59 0.60 0.60 0.76 0.81 0.91 0.94 0.39 0.51 0.58
Leverage Ratio
2.13 2.17 2.27 2.26 2.34 2.50 2.70 2.75 2.26 2.42 2.66
Compound Leverage Factor
1.98 2.03 2.07 2.12 2.17 2.32 2.43 2.54 2.08 2.22 2.37
Debt to Total Capital
41.72% 40.56% 41.67% 43.03% 48.61% 47.70% 49.89% 50.08% 51.92% 55.77% 59.82%
Short-Term Debt to Total Capital
0.00% 1.86% 3.81% 5.64% 0.83% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
41.72% 38.70% 37.86% 37.39% 47.78% 47.70% 49.89% 50.08% 51.92% 55.77% 59.82%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
58.28% 59.44% 58.33% 56.97% 51.39% 52.30% 50.11% 49.92% 48.08% 44.23% 40.18%
Debt to EBITDA
1.67 1.56 1.59 1.71 2.11 1.96 2.08 2.12 2.42 2.81 3.29
Net Debt to EBITDA
1.35 1.15 1.02 1.08 1.56 1.40 1.49 1.46 1.75 2.10 2.40
Long-Term Debt to EBITDA
1.67 1.49 1.45 1.48 2.08 1.96 2.08 2.12 2.42 2.81 3.29
Debt to NOPAT
2.53 2.35 2.36 2.59 3.24 3.01 3.20 3.03 3.51 4.00 4.66
Net Debt to NOPAT
2.04 1.73 1.51 1.64 2.38 2.15 2.29 2.09 2.54 2.99 3.40
Long-Term Debt to NOPAT
2.53 2.24 2.15 2.25 3.19 3.01 3.20 3.03 3.51 4.00 4.66
Altman Z-Score
6.26 6.90 5.85 5.70 6.22 5.91 5.47 5.07 5.19 5.36 4.72
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.47 1.40 1.25 1.28 1.79 1.68 1.59 2.11 2.09 2.16 1.99
Quick Ratio
1.17 1.14 1.08 1.14 1.57 1.51 1.44 1.89 1.79 1.82 1.69
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-33 -26 85 194 -42 213 69 127 -1,744 -1,753 -1,789
Operating Cash Flow to CapEx
732.87% 333.82% 628.53% 1,116.43% 656.10% 942.21% 0.00% 840.57% 943.39% 593.74% 995.35%
Free Cash Flow to Firm to Interest Expense
-2.34 -1.84 5.44 11.48 -2.50 12.70 4.16 7.79 -104.19 -106.01 0.00
Operating Cash Flow to Interest Expense
12.50 6.00 10.49 14.10 8.66 9.27 9.33 13.37 9.84 6.45 0.00
Operating Cash Flow Less CapEx to Interest Expense
10.79 4.20 8.83 12.84 7.34 8.29 9.36 11.78 8.80 5.36 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.55 0.56 0.55 0.54 0.54 0.54 0.52 0.51 0.63 0.62 0.59
Accounts Receivable Turnover
8.20 8.96 9.46 9.11 8.13 8.98 9.44 8.83 9.01 10.00 10.38
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
28.05 27.07 26.13 26.75 26.47 26.13 24.98 24.46 20.43 19.08 17.38
Accounts Payable Turnover
7.97 6.76 6.74 8.18 8.15 7.31 8.46 9.04 8.86 7.81 8.97
Days Sales Outstanding (DSO)
44.51 40.75 38.58 40.07 44.87 40.65 38.66 41.35 40.51 36.51 35.16
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
45.78 53.99 54.12 44.60 44.79 49.91 43.17 40.39 41.20 46.74 40.68
Cash Conversion Cycle (CCC)
-1.27 -13.24 -15.54 -4.54 0.09 -9.27 -4.51 0.96 -0.69 -10.23 -5.51
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,282 3,031 2,825 2,836 3,093 2,845 2,812 2,862 2,900 2,898 2,811
Invested Capital Turnover
0.71 0.76 0.78 0.76 0.72 0.74 0.74 0.72 1.03 0.99 0.99
Increase / (Decrease) in Invested Capital
188 186 13 -26 194 -52 1.04 16 1,886 1,902 1,907
Enterprise Value (EV)
18,745 19,640 16,958 16,314 18,827 18,174 17,648 15,770 16,932 18,715 17,607
Market Capitalization
17,560 18,640 16,085 15,409 17,573 17,067 16,493 14,615 15,674 17,326 16,161
Book Value per Share
$54.09 $52.42 $50.28 $49.60 $47.31 $44.77 $42.47 $43.55 $42.02 $38.71 $35.06
Tangible Book Value per Share
($29.55) ($25.56) ($24.78) ($25.34) ($27.90) ($30.34) ($32.61) ($30.60) ($32.42) ($36.34) ($40.29)
Total Capital
3,529 3,351 3,278 3,318 3,506 3,252 3,233 3,343 3,343 3,333 3,314
Total Debt
1,472 1,359 1,366 1,428 1,704 1,551 1,613 1,674 1,736 1,859 1,982
Total Long-Term Debt
1,472 1,297 1,241 1,241 1,675 1,551 1,613 1,674 1,736 1,859 1,982
Net Debt
1,185 1,000 873 906 1,254 1,107 1,155 1,155 1,258 1,389 1,446
Capital Expenditures (CapEx)
24 26 26 21 22 16 -0.64 26 17 18 15
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-61 -84 -199 -148 -58 -134 -172 -75 -29 -25 -104
Debt-free Net Working Capital (DFNWC)
226 275 294 374 392 310 286 443 448 445 432
Net Working Capital (NWC)
226 213 169 187 363 310 286 443 448 445 432
Net Nonoperating Expense (NNE)
11 9.68 8.20 9.90 11 12 5.34 8.28 10 12 14
Net Nonoperating Obligations (NNO)
1,225 1,040 913 945 1,291 1,145 1,192 1,193 1,292 1,423 1,480
Total Depreciation and Amortization (D&A)
46 43 42 40 39 35 30 36 36 36 37
Debt-free, Cash-free Net Working Capital to Revenue
-2.72% -3.76% -9.03% -6.80% -2.69% -6.31% -8.24% -3.68% -1.47% -1.27% -5.66%
Debt-free Net Working Capital to Revenue
10.02% 12.34% 13.33% 17.18% 18.21% 14.60% 13.71% 21.64% 22.30% 23.14% 23.43%
Net Working Capital to Revenue
10.02% 9.53% 7.66% 8.58% 16.87% 14.60% 13.71% 21.64% 22.30% 23.14% 23.43%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.81 $3.95 $2.35 $4.15 $3.70 $3.91 $1.71 $3.52 $3.44 $3.59 $2.74
Adjusted Weighted Average Basic Shares Outstanding
38.02M 38.01M 38.06M 38.09M 38.10M 38.02M 38.19M 38.28M 38.28M 38.12M 37.86M
Adjusted Diluted Earnings per Share
$3.76 $3.89 $2.33 $4.09 $3.65 $3.84 $1.68 $3.46 $3.38 $3.52 $2.69
Adjusted Weighted Average Diluted Shares Outstanding
38.51M 38.52M 38.62M 38.64M 38.65M 38.64M 38.90M 38.91M 38.98M 38.91M 38.74M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
37.95M 38.03M 37.99M 38.04M 38.12M 38.09M 37.99M 38.15M 38.32M 38.25M 38.08M
Normalized Net Operating Profit after Tax (NOPAT)
156 160 100 168 152 160 85 143 142 149 120
Normalized NOPAT Margin
27.33% 28.08% 17.87% 30.43% 27.86% 29.56% 15.96% 27.05% 27.66% 29.55% 23.98%
Pre Tax Income Margin
30.20% 31.61% 20.83% 34.47% 30.89% 32.31% 20.03% 30.58% 30.43% 31.28% 23.32%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
13.36 13.29 8.28 12.01 10.99 11.29 7.15 10.72 10.19 10.41 0.00
NOPAT to Interest Expense
11.21 11.09 6.28 9.95 9.16 9.58 4.22 8.74 8.49 9.01 0.00
EBIT Less CapEx to Interest Expense
11.66 11.50 6.61 10.74 9.67 10.30 7.19 9.13 9.15 9.33 0.00
NOPAT Less CapEx to Interest Expense
9.50 9.29 4.61 8.68 7.84 8.59 4.26 7.15 7.45 7.92 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
28.63% 28.38% 28.05% 28.97% 29.69% 29.59% 29.60% 26.60% 29.47% 30.26% 31.73%
Augmented Payout Ratio
72.17% 69.99% 71.85% 83.87% 88.73% 78.89% 67.35% 39.82% 29.47% 30.26% 36.42%

Frequently Asked Questions About FactSet Research Systems' Financials

When does FactSet Research Systems's financial year end?

According to the most recent income statement we have on file, FactSet Research Systems' fiscal year ends in August. Their fiscal year 2024 ended on August 31, 2024.

How has FactSet Research Systems' net income changed over the last 9 years?

FactSet Research Systems' net income appears to be on an upward trend, with a most recent value of $537.13 million in 2024, rising from $241.05 million in 2015. The previous period was $468.17 million in 2023. Check out FactSet Research Systems' forecast to explore projected trends and price targets.

What is FactSet Research Systems's operating income?
FactSet Research Systems's total operating income in 2024 was $701.30 million, based on the following breakdown:
  • Total Gross Profit: $1.19 billion
  • Total Operating Expenses: $489.81 million
How has FactSet Research Systems revenue changed over the last 9 years?

Over the last 9 years, FactSet Research Systems' total revenue changed from $1.01 billion in 2015 to $2.20 billion in 2024, a change of 118.8%.

How much debt does FactSet Research Systems have?

FactSet Research Systems' total liabilities were at $2.14 billion at the end of 2024, a 8.6% decrease from 2023, and a 944.7% increase since 2015.

How much cash does FactSet Research Systems have?

In the past 9 years, FactSet Research Systems' cash and equivalents has ranged from $158.91 million in 2015 to $681.87 million in 2021, and is currently $422.98 million as of their latest financial filing in 2024.

How has FactSet Research Systems' book value per share changed over the last 9 years?

Over the last 9 years, FactSet Research Systems' book value per share changed from 12.79 in 2015 to 50.28 in 2024, a change of 293.2%.



This page (NYSE:FDS) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners